BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-0.01%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$6.89B
AUM Growth
+$6.89B
(-8.5%)
Cap. Flow
-$366M
Cap. Flow
% of AUM
-5.31%
Top 10 Holdings %
Top 10 Hldgs %
36.47%
Holding
178
New
7
Increased
49
Reduced
68
Closed
19
Top Buys
| 1 |
Medtronic
MDT
|
$49.2M |
| 2 |
Align Technology
ALGN
|
$30.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$15.6M |
| 4 |
Veeva Systems
VEEV
|
$14.1M |
| 5 |
Legend Biotech
LEGN
|
$7.35M |
Top Sells
| 1 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$159M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$27.3M |
| 3 |
DexCom
DXCM
|
$27.1M |
| 4 |
Cigna
CI
|
$26.9M |
| 5 |
Elevance Health
ELV
|
$26M |
Sector Composition
| 1 | Healthcare | 99.07% |
| 2 | Industrials | 0.84% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLK
101
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $5.4M | 0.08% |
239,624
-11,561
| -5% | -$260K |
|
102
Zai Lab
ZLAB
$3.48B
| $5.3M | 0.08% |
159,400
+69,400
| +77% | +$2.31M |
|
|
VRNA
103
Verona Pharma
VRNA
$9.18B
| $5.27M | 0.08% |
+262,683
| New | +$5.27M |
|
104
AstraZeneca
AZN
$255B
| $4.97M | 0.07% |
71,600
+3,100
| +5% | +$215K |
|
105
BioMarin Pharmaceuticals
BMRN
$11.3B
| $4.71M | 0.07% |
48,445
-12,240
| -20% | -$1.19M |
|
|
SGEN
106
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.6M | 0.07% |
22,700
+74
| +0.3% | +$15K |
|
107
Supernus Pharmaceuticals
SUPN
$2.52B
| $4.45M | 0.06% |
122,881
+11,835
| +11% | +$429K |
|
|
MTEM
108
DELISTED
Molecular Templates, Inc.
MTEM
| $4.27M | 0.06% |
11,230,003
-48,000
| -0.4% | -$18.2K |
|
109
Eli Lilly
LLY
$661B
| $3.7M | 0.05% |
10,764
-291
| -3% | -$99.9K |
|
110
Johnson & Johnson
JNJ
$429B
| $3.55M | 0.05% |
22,905
-3,122
| -12% | -$484K |
|
111
American Well
AMWL
$112M
| $3.45M | 0.05% |
1,462,178
-490,237
| -25% | -$1.16M |
|
112
AbbVie
ABBV
$374B
| $2.74M | 0.04% |
17,176
+976
| +6% | +$156K |
|
113
Cencora
COR
$57.2B
| $2.55M | 0.04% |
15,910
+5,700
| +56% | +$913K |
|
114
Sight Sciences
SGHT
$199M
| $2.5M | 0.04% |
286,284
-8,322
| -3% | -$72.7K |
|
115
Kosmos Energy
KOS
$803M
| $2.37M | 0.03% |
318,300
| – | – |
|
116
Guardant Health
GH
$8.11B
| $1.93M | 0.03% |
82,197
-53,258
| -39% | -$1.25M |
|
117
Cytokinetics
CYTK
$5.98B
| $1.91M | 0.03% |
54,200
| – | – |
|
118
Alkermes
ALKS
$4.95B
| $1.81M | 0.03% |
64,200
+28,700
| +81% | +$809K |
|
119
CVS Health
CVS
$93B
| $1.7M | 0.02% |
22,814
-181,391
| -89% | -$13.5M |
|
120
Labcorp
LH
$22.8B
| $1.6M | 0.02% |
6,988
+3,658
| +110% | +$839K |
|
121
Krystal Biotech
KRYS
$4.35B
| $1.47M | 0.02% |
18,300
| – | – |
|
122
BridgeBio Pharma
BBIO
$9.91B
| $1.37M | 0.02% |
+82,600
| New | +$1.37M |
|
|
KRTX
123
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.33M | 0.02% |
7,300
| – | – |
|
|
ISEE
124
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $1.29M | 0.02% |
52,900
+11,100
| +27% | +$270K |
|
125
Viridian Therapeutics
VRDN
$1.59B
| $1.17M | 0.02% |
46,100
| – | – |
|